# reload+after+2024-01-22 14:44:09.832907
address1§105 Bradford Road
address2§Suite 420
city§Wexford
state§PA
zip§15090
country§United States
phone§724 934 6467
website§https://coeptistx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania.
fullTimeEmployees§4
companyOfficers§[{'maxAge': 1, 'name': 'Mr. David  Mehalick', 'age': 54, 'title': 'Co-Founder, Chairman of the Board, CEO & President', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 361615, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Christine Elise Sheehy', 'age': 56, 'title': 'Co-Founder and VP of Compliance & Corporate Secretary', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 225999, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Daniel Alexander Yerace', 'age': 40, 'title': 'Co-Founder, VP of Operations & Director', 'yearBorn': 1983, 'fiscalYear': 2022, 'totalPay': 360346, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brian  Cogley M.B.A.', 'age': 37, 'title': 'Chief Financial Officer', 'yearBorn': 1986, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Colleen  Delaney M.D., M.Sc.', 'age': 56, 'title': 'CSO & Chief Medical Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.818
currency§USD
dateShortInterest§1702598400
forwardEps§-0.77
exchange§NCM
quoteType§EQUITY
shortName§Coeptis Therapeutics Holdings, 
longName§Coeptis Therapeutics Holdings, Inc.
firstTradeDateEpochUtc§1608215400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§820436ab-e838-3404-bbe6-691814b0374c
gmtOffSetMilliseconds§-18000000
targetHighPrice§4.0
targetLowPrice§3.0
targetMeanPrice§3.5
targetMedianPrice§3.5
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§2
quickRatio§2.421
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
